Cost-effectiveness of multidisciplinary management of tinnitus at a specialized tinnitus centre

R. Cima, M.A. Joore, I. Maes, D. Scheyen, A. el Refaie, D.M. Baguley, J.W.S. Vlaeyen, L. Anteunis

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

Tinnitus is a common chronic health condition that affects 10% to 20% of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.
Original languageEnglish
Article number29
JournalBMC Health Services Research
Volume9
DOIs
Publication statusPublished - 1 Jan 2009

Cite this

@article{6ec921d3ed9e42f6948167d8dd9ff108,
title = "Cost-effectiveness of multidisciplinary management of tinnitus at a specialized tinnitus centre",
abstract = "Tinnitus is a common chronic health condition that affects 10{\%} to 20{\%} of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.",
author = "R. Cima and M.A. Joore and I. Maes and D. Scheyen and {el Refaie}, A. and D.M. Baguley and J.W.S. Vlaeyen and L. Anteunis",
year = "2009",
month = "1",
day = "1",
doi = "10.1186/1472-6963-9-29",
language = "English",
volume = "9",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central Ltd",

}

Cost-effectiveness of multidisciplinary management of tinnitus at a specialized tinnitus centre. / Cima, R.; Joore, M.A.; Maes, I.; Scheyen, D.; el Refaie, A.; Baguley, D.M.; Vlaeyen, J.W.S.; Anteunis, L.

In: BMC Health Services Research, Vol. 9, 29, 01.01.2009.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Cost-effectiveness of multidisciplinary management of tinnitus at a specialized tinnitus centre

AU - Cima, R.

AU - Joore, M.A.

AU - Maes, I.

AU - Scheyen, D.

AU - el Refaie, A.

AU - Baguley, D.M.

AU - Vlaeyen, J.W.S.

AU - Anteunis, L.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Tinnitus is a common chronic health condition that affects 10% to 20% of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.

AB - Tinnitus is a common chronic health condition that affects 10% to 20% of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.

U2 - 10.1186/1472-6963-9-29

DO - 10.1186/1472-6963-9-29

M3 - Article

VL - 9

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

M1 - 29

ER -